Big Med-Tech Firms Train Device Regulators In Emerging Markets
This article was originally published in The Gray Sheet
The largest multinational medical device companies are making an effort not only to lobby governments in emerging foreign markets to influence regulations, but to actually train the regulators on what industry sees as best practices
You may also be interested in...
At $1.5 billion, India's medical device market is established, but the country's regulatory system for the products is anything but
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.